CryoPort (NASDAQ:CYRX) Stock Price Passes Above 200-Day Moving Average - Time to Sell?

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.65 and traded as high as $7.72. CryoPort shares last traded at $7.50, with a volume of 328,354 shares.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Morgan Stanley cut their target price on CryoPort from $8.00 to $7.00 and set an "equal weight" rating for the company in a research note on Monday, May 5th. BTIG Research lowered their price target on shares of CryoPort from $13.00 to $10.00 and set a "buy" rating for the company in a report on Monday, July 7th. Guggenheim reiterated a "buy" rating and set a $10.00 price target on shares of CryoPort in a report on Wednesday, April 16th. Needham & Company LLC reiterated a "buy" rating and set a $11.00 price target on shares of CryoPort in a report on Thursday, May 8th. Finally, UBS Group upped their price target on shares of CryoPort from $10.00 to $11.00 and gave the stock a "buy" rating in a report on Tuesday, April 1st. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $10.88.

CryoPort Stock Performance

The company has a debt-to-equity ratio of 0.51, a quick ratio of 5.24 and a current ratio of 5.56. The stock has a fifty day simple moving average of $6.84 and a two-hundred day simple moving average of $6.65. The stock has a market capitalization of $360.51 million, a price-to-earnings ratio of -3.08 and a beta of 1.89.

CryoPort (NASDAQ:CYRX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. CryoPort had a negative return on equity of 11.03% and a negative net margin of 50.15%. The firm had revenue of $41.04 million during the quarter, compared to the consensus estimate of $56.19 million. Analysts forecast that CryoPort, Inc. will post -0.99 earnings per share for the current fiscal year.

Insider Buying and Selling

In other CryoPort news, Director Robert J. Hariri sold 12,500 shares of CryoPort stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $6.10, for a total transaction of $76,250.00. Following the transaction, the director owned 8,061 shares of the company's stock, valued at $49,172.10. This trade represents a 60.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Edward J. Zecchini sold 51,500 shares of CryoPort stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $6.84, for a total transaction of $352,260.00. Following the transaction, the insider directly owned 90,411 shares in the company, valued at approximately $618,411.24. This represents a 36.29% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 449,719 shares of company stock worth $3,042,327 over the last 90 days. Company insiders own 10.00% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Thrivent Financial for Lutherans purchased a new position in CryoPort in the fourth quarter worth $299,000. American Century Companies Inc. boosted its position in CryoPort by 12.0% during the fourth quarter. American Century Companies Inc. now owns 51,443 shares of the company's stock valued at $400,000 after buying an additional 5,508 shares during the period. Fox Run Management L.L.C. purchased a new stake in CryoPort during the fourth quarter valued at about $111,000. LPL Financial LLC boosted its position in CryoPort by 1,366.1% during the fourth quarter. LPL Financial LLC now owns 436,766 shares of the company's stock valued at $3,398,000 after buying an additional 406,976 shares during the period. Finally, Perkins Capital Management Inc. raised its stake in shares of CryoPort by 1,286.1% during the fourth quarter. Perkins Capital Management Inc. now owns 159,400 shares of the company's stock valued at $1,240,000 after acquiring an additional 147,900 shares during the last quarter. 92.90% of the stock is currently owned by hedge funds and other institutional investors.

CryoPort Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.